Caregen Co Ltd
214370
Company Profile
Business description
Caregen Co Ltd is in the business of research and marketing of Biomimetic peptides and Growth factors. It also offers customized Biomimetic Peptides and toll manufacturing services. The firm's business areas include research and development, production and supply of active ingredients, production and global distribution of Cosmeceuticals and Medical devices and global operation of hair care center. The company's products include CG-Illugen, CG-Nugenerin, CG-Fibrofillin, CG-EGF etc.
Contact
46-38, Ls-Ro 91beon-Gil
Dongan-Gu
Gyeonggi-Do
Anyang-Si431848
KORT: +82 314209200
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2025
Employees
193
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
Stellar first half profits but increasing competition will lower future rate increases.
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
With today’s share drop, we think Lilly stock looks fairly valued.
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Positive news for income investors as yield exceeds 5%.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,102.80 | 26.20 | 0.29% |
| CAC 40 | 7,743.00 | 33.68 | 0.44% |
| DAX 40 | 24,162.86 | 29.64 | -0.12% |
| Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
| FTSE 100 | 9,095.73 | 5.04 | -0.06% |
| HKSE | 24,907.60 | 48.78 | 0.20% |
| NASDAQ | 21,450.02 | 207.32 | 0.98% |
| Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
| NZX 50 Index | 12,916.47 | 71.84 | 0.56% |
| S&P 500 | 6,389.45 | 49.45 | 0.78% |
| S&P/ASX 200 | 8,831.40 | 24.30 | 0.28% |
| SSE Composite Index | 3,653.50 | 18.37 | 0.51% |